Two Sigma Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.22M Sell
556,971
-223,038
-29% -$2.09M 0.01% 1171
2025
Q1
$9.58M Buy
780,009
+110,186
+16% +$1.35M 0.02% 757
2024
Q4
$8.86M Sell
669,823
-216,671
-24% -$2.86M 0.02% 768
2024
Q3
$17.1M Sell
886,494
-44,453
-5% -$856K 0.04% 522
2024
Q2
$19.1M Buy
930,947
+212,395
+30% +$4.36M 0.04% 449
2024
Q1
$17.1M Buy
718,552
+182,614
+34% +$4.35M 0.04% 454
2023
Q4
$11.6M Buy
535,938
+104,373
+24% +$2.26M 0.03% 569
2023
Q3
$6.27M Buy
+431,565
New +$6.27M 0.02% 743
2023
Q2
Sell
-69,169
Closed -$1.46M 3161
2023
Q1
$1.46M Buy
+69,169
New +$1.46M ﹤0.01% 1562
2022
Q3
Sell
-94,474
Closed -$1.82M 2740
2022
Q2
$1.82M Sell
94,474
-129,584
-58% -$2.49M 0.01% 1203
2022
Q1
$3.89M Sell
224,058
-98,662
-31% -$1.71M 0.01% 1006
2021
Q4
$7.06M Buy
322,720
+212,740
+193% +$4.66M 0.02% 779
2021
Q3
$2.1M Sell
109,980
-2,359
-2% -$45.1K ﹤0.01% 1332
2021
Q2
$1.93M Sell
112,339
-129,075
-53% -$2.22M ﹤0.01% 1345
2021
Q1
$5.4M Sell
241,414
-353,457
-59% -$7.9M 0.01% 791
2020
Q4
$13.2M Buy
594,871
+368,182
+162% +$8.19M 0.04% 434
2020
Q3
$3.35M Sell
226,689
-128,122
-36% -$1.89M 0.01% 747
2020
Q2
$5.26M Buy
354,811
+290,006
+448% +$4.3M 0.03% 522
2020
Q1
$711K Buy
64,805
+8,611
+15% +$94.5K 0.01% 1120
2019
Q4
$493K Buy
56,194
+38,459
+217% +$337K ﹤0.01% 1709
2019
Q3
$132K Buy
+17,735
New +$132K ﹤0.01% 1806
2019
Q1
Sell
-13,487
Closed -$60K 2426
2018
Q4
$60K Sell
13,487
-9,578
-42% -$42.6K ﹤0.01% 1996
2018
Q3
$186K Buy
+23,065
New +$186K ﹤0.01% 1877
2018
Q1
Sell
-30,930
Closed -$271K 2315
2017
Q4
$271K Buy
+30,930
New +$271K ﹤0.01% 1960